These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34608724)

  • 21. More frequent use of health care services among distressed compared with nondistressed survivors of lymphoma and chronic lymphocytic leukemia: Results from the population-based PROFILES registry.
    Arts LPJ; Oerlemans S; Tick L; Koster A; Roerdink HTJ; van de Poll-Franse LV
    Cancer; 2018 Jul; 124(14):3016-3024. PubMed ID: 29698556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. There's no sugar-coating psychological distress and illness perceptions in gestational diabetes mellitus: depression and anxiety are associated with negative illness perceptions.
    Maguire PA; Cummings JA; Reay RE; Nolan CJ; Looi JCL
    Australas Psychiatry; 2022 Feb; 30(1):64-69. PubMed ID: 34488491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors predicting first-time hepatitis C virus testing uptake among men who have sex with men in China: an observational prospective cohort study.
    Wang Z; Mo PKH; Fang Y; Ip M; Lau JTF
    Sex Transm Infect; 2020 Jun; 96(4):258-264. PubMed ID: 31919274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between illness representation and psychological distress in stroke patients: A systematic review and meta-analysis.
    Pai HC; Li CC; Tsai SM; Pai YC
    Int J Nurs Stud; 2019 Jun; 94():42-50. PubMed ID: 30933872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom.
    Yang L; Chen X; Liu Z; Sun W; Yu D; Tang H; Zhang Z
    Int J Gen Med; 2021; 14():9297-9306. PubMed ID: 34887677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying illness perception schemata and their association with depression and quality of life in cardiac patients.
    Le Grande MR; Elliott PC; Worcester MU; Murphy BM; Goble AJ; Kugathasan V; Sinha K
    Psychol Health Med; 2012; 17(6):709-22. PubMed ID: 22416847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.
    Soumerai JD; Ni A; Darif M; Londhe A; Xing G; Mun Y; Kay NE; Shanafelt TD; Rabe KG; Byrd JC; Chanan-Khan AA; Furman RR; Hillmen P; Jones J; Seymour JF; Sharman JP; Ferrante L; Mobasher M; Stark T; Reddy V; Dreiling LK; Bhargava P; Howes A; James DF; Zelenetz AD
    Lancet Haematol; 2019 Jul; 6(7):e366-e374. PubMed ID: 31109827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
    Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
    Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study.
    Seymour JF; Ma S; Brander DM; Choi MY; Barrientos J; Davids MS; Anderson MA; Beaven AW; Rosen ST; Tam CS; Prine B; Agarwal SK; Munasinghe W; Zhu M; Lash LL; Desai M; Cerri E; Verdugo M; Kim SY; Humerickhouse RA; Gordon GB; Kipps TJ; Roberts AW
    Lancet Oncol; 2017 Feb; 18(2):230-240. PubMed ID: 28089635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial.
    Howard DR; Munir T; McParland L; Rawstron AC; Chalmers A; Gregory WM; O'Dwyer JL; Smith A; Longo R; Varghese A; Smith A; Hillmen P
    Health Technol Assess; 2017 May; 21(28):1-374. PubMed ID: 28628003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Illness perception in patients with migraine: An exploratory study in a tertiary care headache centre.
    Sirri L; Pierangeli G; Cevoli S; Cortelli P; Grandi S; Tossani E
    J Psychosom Res; 2018 Aug; 111():52-57. PubMed ID: 29935755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study.
    Holtzer-Goor KM; Schaafsma MR; Joosten P; Posthuma EF; Wittebol S; Huijgens PC; Mattijssen EJ; Vreugdenhil G; Visser H; Peters WG; Erjavec Z; Wijermans PW; Daenen SM; van der Hem KG; van Oers MH; Uyl-de Groot CA
    Qual Life Res; 2015 Dec; 24(12):2895-906. PubMed ID: 26205768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.
    Shanafelt TD; Bowen D; Venkat C; Slager SL; Zent CS; Kay NE; Reinalda M; Sloan JA; Call TG
    Br J Haematol; 2007 Oct; 139(2):255-64. PubMed ID: 17897301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Illness perceptions in mothers with postpartum depression.
    Baines T; Wittkowski A; Wieck A
    Midwifery; 2013 Jul; 29(7):779-86. PubMed ID: 22901491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From despair to hope: a longitudinal study of illness perceptions and coping in a psycho-educational group intervention for women with breast cancer.
    Fischer MJ; Wiesenhaan ME; Does-den Heijer A; Kleijn WC; Nortier JW; Kaptein AA
    Br J Health Psychol; 2013 Sep; 18(3):526-45. PubMed ID: 23006141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agents.
    Waweru C; Kaur S; Sharma S; Mishra N
    Curr Med Res Opin; 2020 Sep; 36(9):1481-1495. PubMed ID: 32634056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the relationship between cognitive illness representations and poor emotional health and their combined association with diabetes self-care. A systematic review with meta-analysis.
    Hudson JL; Bundy C; Coventry PA; Dickens C
    J Psychosom Res; 2014 Apr; 76(4):265-74. PubMed ID: 24630175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the common-sense model to understand health outcomes for medically unexplained symptoms: a meta-analysis.
    McAndrew LM; Crede M; Maestro K; Slotkin S; Kimber J; Phillips LA
    Health Psychol Rev; 2019 Dec; 13(4):427-446. PubMed ID: 30196755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A network analysis of the Brief Illness Perception Questionnaire in patients with rheumatic diseases and human immunodeficiency virus infection.
    Shim EJ; Jeong D; Song YW; Lee SH; Kim NJ; Hahm BJ
    Psychol Health; 2020 Jul; 35(7):838-853. PubMed ID: 31690118
    [No Abstract]   [Full Text] [Related]  

  • 40. Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study.
    Fink AM; Bahlo J; Robrecht S; Al-Sawaf O; Aldaoud A; Hebart H; Jentsch-Ullrich K; Dörfel S; Fischer K; Wendtner CM; Nösslinger T; Ghia P; Bosch F; Kater AP; Döhner H; Kneba M; Kreuzer KA; Tausch E; Stilgenbauer S; Ritgen M; Böttcher S; Eichhorst B; Hallek M
    Lancet Haematol; 2017 Oct; 4(10):e475-e486. PubMed ID: 28916311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.